Oculis Holding AG
NASDAQ:OCS
11.95 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0.222 | 0.185 | 0.219 | 0.25 | 0.24 | 0.214 | 0.202 | 0.24 | 0.248 | 0.387 | 0.02 |
Cost of Revenue
| 0 | 10.856 | 8.029 | 8.872 | 6.198 | 6.173 | 6.889 | 4.592 | 6.702 | 5.372 | 3.529 | 1.778 |
Gross Profit
| 0 | -10.634 | -7.844 | -8.653 | -5.948 | -5.934 | -6.675 | -4.39 | -6.462 | -5.124 | -3.142 | -1.758 |
Gross Profit Ratio
| 0 | -47.901 | -42.4 | -39.511 | -23.792 | -24.775 | -31.192 | -21.733 | -26.925 | -20.659 | -8.119 | -87.9 |
Reseach & Development Expenses
| 16.465 | 10.856 | 8.029 | 8.872 | 6.198 | 6.148 | 6.889 | 4.592 | 6.702 | 5.372 | 3.529 | 1.778 |
General & Administrative Expenses
| 5.213 | 4.052 | 4.099 | 3.647 | 4.273 | 2.703 | 1.882 | 1.67 | 2.776 | 2.072 | 1.473 | 0.985 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 5.213 | 4.052 | 4.099 | 3.647 | 4.273 | 2.703 | 1.882 | 1.67 | 2.776 | 2.072 | 1.473 | 0.985 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 22.485 | 15.328 | 12.184 | 12.959 | 10.745 | 9.961 | 11.113 | 6.873 | 4.182 | 2.987 | 4.682 | 2.904 |
Operating Income
| -22.485 | -15.328 | -12.184 | -12.959 | -10.745 | -44.824 | -11.113 | -6.873 | -9.238 | -7.195 | -4.681 | -2.904 |
Operating Income Ratio
| 0 | -69.045 | -65.859 | -59.174 | -42.98 | -187.157 | -51.93 | -34.025 | -38.492 | -29.012 | -12.096 | -145.2 |
Total Other Income Expenses Net
| 1.103 | -1.275 | -0.972 | -5.079 | -2.217 | -34.684 | 3.183 | -1.302 | -3.064 | -2.555 | 0.659 | -0.545 |
Income Before Tax
| -20.809 | -16.063 | -12.512 | -17.529 | -12.763 | -45.891 | -9.197 | -9.948 | -12.302 | -9.75 | -5.535 | -4.986 |
Income Before Tax Ratio
| 0 | -72.356 | -67.632 | -80.041 | -51.052 | -191.612 | -42.977 | -49.248 | -51.258 | -39.313 | -14.302 | -249.3 |
Income Tax Expense
| 0.03 | 0.03 | -0.013 | -0.116 | 0.114 | 0.124 | -0.014 | 0.006 | 0.042 | 0.032 | 0.011 | -0.01 |
Net Income
| -20.839 | -16.093 | -12.499 | -17.413 | -12.877 | -46.015 | -9.183 | -9.954 | -12.344 | -9.782 | -5.547 | -4.976 |
Net Income Ratio
| 0 | -72.491 | -67.562 | -79.511 | -51.508 | -192.129 | -42.911 | -49.277 | -51.433 | -39.442 | -14.333 | -248.8 |
EPS
| -0.51 | -0.44 | -0.34 | -0.48 | -0.38 | -3.57 | -0.28 | -0.3 | -3.64 | -2.92 | -1.97 | -0.15 |
EPS Diluted
| -0.51 | -0.44 | -0.34 | -0.48 | -0.38 | -3.57 | -0.28 | -0.3 | -3.64 | -2.92 | -1.97 | -0.15 |
EBITDA
| -21.736 | -14.674 | -11.454 | -12.366 | -10.51 | -9.865 | -10.98 | -6.738 | -9.205 | -7.162 | -4.614 | -2.837 |
EBITDA Ratio
| 0 | -66.099 | -61.914 | -56.466 | -42.04 | -41.19 | -51.308 | -33.356 | -38.352 | -28.877 | -11.922 | -141.85 |